Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection

By E. Fiebig, D. Wright, B. Rawal, P. Garrett, R. Schumacher, L. Peddada, C. Heldebrant, Richard Smith, A. Conrad, S. Kleinman and 1 more. AIDS (London), 2003

1,343 citations recorded by the source corpus.

Subfields: Infectious Diseases, Virology

View Paper: https://www.semanticscholar.org/paper/ca16db5d2b8139ae3789899ac9db035e442686d4

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Infectious Diseases

Christophe Fraser

In Virology

Citations in the corpus

HIV-1 transmission, by stage of infection. (2008, methodology): “These transmission rates are placed on the graph according to published mean viral loads during this period: primary infection, 100 million HIV-1 RNA copies per mL of blood plasma [33]; asymptomatic infection, 12,500 HIV-1 RNA copies per mL of blood plasma (mean viral load in study of the Rakai coho”
Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies (2009, neutral): “c Fiebig stage as previously defined (13).”
Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia (2008, background): “Critical questions for understanding the role of early HIV-1 antibodies in the control of HIV-1 are, first, what are the nature and timing of the earliest anti-HIV-1 antibodies and, second, what are the contributions of these antibodies in the control of viral replication after transmission? In this”
Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection (2008, methodology): “(A) Fiebig stages (28) are defined by HIV-1 clinical laboratory test results.”
Deciphering Human Immunodeficiency Virus Type 1 Transmission and Early Envelope Diversification by Single-Genome Amplification and Sequencing (2008, methodology): “The 95% confidence intervals (CI) were calculated and reported elsewhere (8).”